The Parliamentary Budget Officer is estimating that a new national pharmacare program would cost the federal government a little over $19 billion per year, a price-tag that could grow to $22.6 billion a year by 2021.
The federal fiscal watchdog, which provides non-partisan financial advice to Parliament, issued a report on Thursday outlining the expected financial consequences of granting universal government coverage on most prescription drugs — something that is already a reality in many countries with universal health care.
Full article at: Global News